Available IPD datapackage for study 'A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma'
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00007113.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to provide continued access to ixazomib and/or lenalidomide to
participants who are continuing to have clinical benefit and to continue collecting relevant
safety data to monitor safety in participants with Newly Diagnosed Multiple Myeloma (NDMM)
who are not eligible for stem cell transplant.
提供机构：
Vivli
创建时间：
2023-04-10
